Spot on EV, relatively low volume since announcement, and the long delays gave everyone that want to be in ample time to get set, so mostly full, hence a few sellers push the price down. Seem to have pushed through them and with more news flow expected this quarter things should tighten up and tick higher.
I am hoping the Quarterly will give a little more commentary re the trials, and an update on when we expect to see the additional data.
Waiting for a nutraceutical deal to be announced now we have safety data. Could be the next catalyst?
NTI Price at posting:
6.0¢ Sentiment: Buy Disclosure: Held
